Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 19, 2023 | SVP/GM, Vascular Access | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 13,453 | -- | -- | |
| Jul 19, 2023 | SVP/GM, Vascular Access | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 13,453 | -- | -- | |
| Jul 19, 2023 | SVP/GM, VIT | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 11,782 | -- | -- | |
| Jul 19, 2023 | SVP/GM, VIT | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 11,782 | -- | -- | |
| Jul 19, 2023 | Director, President and CEO | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 108,871 | -- | -- | |
| Jul 19, 2023 | Director, President and CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 108,871 | -- | -- | |
| Jul 19, 2023 | SVP Global Operations and R&D | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,081 | -- | -- | |
| Jul 19, 2023 | SVP Global Operations and R&D | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,081 | -- | -- | |
| Jul 19, 2023 | EVP and CFO | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 30,242 | -- | -- | |
| Jul 19, 2023 | EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 30,242 | -- | -- |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.